HC Wainwright & Co. Downgrades Clovis Oncology to Neutral

HC Wainwright & Co. analyst Edward White downgrades Clovis Oncology (NASDAQ:CLVS) from Buy to Neutral.

HC Wainwright & Co. analyst Edward White downgrades Clovis Oncology (NASDAQ:CLVS) from Buy to Neutral.

Total
0
Shares
Related Posts